Viewing Study NCT01476657


Ignite Creation Date: 2025-12-24 @ 6:51 PM
Ignite Modification Date: 2026-01-04 @ 9:41 PM
Study NCT ID: NCT01476657
Status: TERMINATED
Last Update Posted: 2021-03-17
First Post: 2011-11-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Study of Duvelisib in Patients With Advanced Hematologic Malignancies
Sponsor: SecuraBio
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hematologic Malignancies View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Phase 1 View